A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The first European cancer center, Gustave Roussy is a care, research and teaching center, which takes care of patients suffering from all types of cancer. Gustave Roussy places innovation at the heart of a human, scientific and technological revolution to fight cancer.
Villejuif, France Clinical Trial Location
Gustave Roussy Cancer Campus
114 Rue Edouard Vaillant
94800, Villejuif, France